Dow Down 0.38% Nasdaq Up 0.14%

Theravance Inc. (THRX)

-NasdaqGS
23.04 Down 0.53(2.23%) 2:04PM EDT - Nasdaq Real Time Price
Prev Close:23.56
Open:23.74
Bid:22.98 x 300
Ask:23.00 x 100
1y Target Est:29.86
Beta:0.72
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:22.84 - 23.84
52wk Range:20.23 - 34.53
Volume:381,917
Avg Vol (3m):992,405
Market Cap:2.65B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 2.23%2.65B
AZNDown 1.70%94.37B
CBSTDown 0.58%5.20B
PFEDown 0.31%185.79B

Key Statistics

Forward P/E (1 yr):287.25
P/S (ttm):1,194.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.21
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback